FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly laboratory diagnostics. There is disclosed method for determination of fibrin monomer self-assembly time. The method can be used for blood analysis in disturbed haemostasis system. It involves determination of coagulation time with thrombin with urea added in concentration 180 g/l. Thrombin applied therefor is characterised with activity 4-6 seconds. The offered method allows estimating both delayed and accelerated fibrin monomer self-assembly in relevant typical clinical situations.
EFFECT: higher accuracy of determination fibrin monomer self-assembly time.
4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING FACTOR XIII ACTIVITY | 2001 |
|
RU2204141C2 |
METHOD FOR DETERMINING FIBRIN MONOMER POLYMERIZATION DISORDERS IN THE PATIENT BLOOD PLASMA | 0 |
|
SU1712873A1 |
SOLUBLE FIBRIN MONOMER PREPARATION METHOD | 2003 |
|
RU2253474C1 |
HEMOSTATIC SPONGE AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2628809C1 |
HAEMOSTATIC SPONGE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2618896C1 |
METHOD FOR DETECTING PLASMINOGEN | 2000 |
|
RU2189590C2 |
HEMOSTATIC COATING IN THE FORM OF POWDER | 2017 |
|
RU2660582C1 |
METHOD FOR DETERMINING FIBRINOGEN DURING RECALCIFICATION OF CITRATE PLASMA AND EVALUATING ITS FUNCTIONALITY | 2019 |
|
RU2703541C1 |
METHOD OF DETERMINING OXIDATIVE MODIFICATION OF FIBRINOGEN IN BLOOD PLASMA BY CONTENT OF CARBONYL GROUPS IN FIBRINOUS CLOT | 2014 |
|
RU2595806C2 |
METHOD FOR COMMERCIAL PRODUCTION OF THROMBIN | 2010 |
|
RU2457248C2 |
Authors
Dates
2009-09-10—Published
2007-07-24—Filed